CatalystWireBeta

UK small-cap RNS · 20 Oct 2025

The key announcements of UK small & mid caps under £2bn on 20 Oct 2025 – situations they move are marked, with the share price since.

Key = all announcements except routine filings (voting rights, buybacks, holdings, director forms), plus director dealings and holdings that are part of a situation. Not investment advice.

DateCompanyMcap ↕TypeAnnouncement
20 Oct Hunting HTG £585m Routine Transaction in Own Shares
20 Oct Anglo-Eastern Plantations AEP £601m Routine Transaction in Own Shares
20 Oct Playtech PTEC £1,036m Routine Transaction in Own Shares
20 Oct Strip Tinning Holdings STG £4.3m Trading and Business Update
Strip Tinning Holdings plc ("Strip Tinning" or the "Company"), a leading supplier of specialist connection systems for battery modules and automotive glazing applications, is pleased to report it has now received the purchase order for its battery system …
20 Oct SSP Group SSPG £1,343m Routine Transaction in Own Shares
20 Oct AO World AO. £511m Routine Transaction in Own Shares
20 Oct Aptitude Software Group APTD £116m Routine Transaction in Own Shares
20 Oct Trainline TRN £710m Routine Transaction in Own Shares
20 Oct Hostelworld Group HSW £103m Routine Transaction in Own Shares
20 Oct Caledonia Investments CLDN £1,872m Routine Transaction in Own Shares
20 Oct Pulsar Helium Inc PLSR £144m Warrant Exercise and TVR
Application has been made to the London Stock Exchange plc for the admission of the 108,675 new Common Shares issued pursuant to abovementioned warrant exercises, to be admitted to trading on AIM, which is expected to occur and dealings commence at 8.00 a.m. …
20 Oct City of London Investment Group CLIG £217m Trading update Trading Update - Quarter to 30 September 2025
("City of London" or "the Group" or "the Company" or "CLIG")
20 Oct Metals Exploration MTL £498m Exercise of Warrants and Total Voting Rights
Metals Exploration plc (AIM: MTL) ("Metals Exploration" or the "Company"), a gold producer, exploration, and development company with assets in the Philippines and Nicaragua, announces that it has received notice of exercise of an option in respect of 868,410 …
20 Oct Central Asia Metals CAML £231m Routine Transaction in Own Shares
20 Oct LSL Property Services LSL £249m Routine Transaction in Own Shares and Total Voting Rights
20 Oct Eurocell ECEL £143m Routine Transaction in Own Shares
20 Oct Currys CURY £1,473m Routine Transaction in Own Shares
20 Oct Future FUTR £252m Routine Transaction in Own Shares
20 Oct Water Intelligence WATR £46m Routine Transaction in Own Shares and Total Voting Rights
20 Oct Science Group SAG £229m Routine Transaction in Own Shares
20 Oct Hargreaves Services HSP £265m Disposal of a part (break-up) First Tranche of Renewable Energy Land Assets Sold
Hargreaves Services plc (AIM: HSP), a diversified group delivering services to the environmental, infrastructure and property sectors, announces completion of the sale of the first tranche of renewable energy land assets (the "Sold Assets") to Meadow …
20 Oct On The Beach Group OTB £233m Routine Transaction in Own Shares
20 Oct Mercia Asset Management MERC £128m Routine Transaction in Own Shares
20 Oct Vistry Group VTY £806m Routine Transaction in Own Shares
20 Oct accesso Technology Group ACSO £99m Routine Transaction in Own Shares
20 Oct Wickes Group WIX £506m Routine Transaction in Own Shares
20 Oct IWG IWG £1,745m Routine Transaction in Own Shares
20 Oct Chrysalis Investments Limited CHRY £295m Routine Transaction in Own Shares
20 Oct Impax Asset Management Group IPX £110m Routine Transaction in Own Shares
20 Oct Morgan Advanced Materials MGAM £674m Routine Transaction in Own Shares
20 Oct Kainos Group KNOS £1,520m Routine Transaction in Own Shares
20 Oct Johnson Service Group JSG £508m Routine Transaction in Own Shares
20 Oct PayPoint PAY £418m Routine Transaction in Own Shares
20 Oct Macfarlane Group MACF £124m Routine Transaction in Own Shares
20 Oct Ultimate Products ULTP £40m EBT Share Purchase
Further to its announcement of 1 August 2025, Ultimate Products, the owner of a number of leading homeware brands including Salter (the UK's oldest houseware brand, est.1760) and Beldray (est.1872), was notified that on 17 October 2025, JTC Employer Solutions …
20 Oct Galliford Try GFRD £675m Transformational contract / build-out Contract
Galliford Try's Building business has been appointed to a £3 billion affordable homes framework by major Registered Provider (RP), The Hyde Group.
20 Oct Essentra ESNT £326m Routine Transaction in Own Shares
20 Oct Switch Metals Plc SWT £6.6m Alluvium Exploration Programme Underway at Issia
Switch Metals (LSE: SWT), the critical metals focused mining company with assets located in Côte d'Ivoire, is pleased to announce that, following the successful completion of its mineral resource estimate ("MRE") pitting programme, the Company has started a …
20 Oct Synergia Energy Ltd SYN £1.3m Cambay PSC Update
Antelopus Selan Energy Limited (formerly Selan Exploration Technology Limited), ("Selan") has informed the Company of the following planned activity on the Cambay PSC:
20 Oct DP Poland DPP £58m Renewal of Master Franchise Agreement
The renewed Master Franchise Agreement became effective on 1 September 2025 and extends for ten years, through to 31 August 2035.
20 Oct Eagle Eye Solutions Group EYE £137m Routine Transaction in Own Shares
20 Oct Kier Group KIE £1,303m Routine Transaction in Own Shares
20 Oct Kavango Resources KAV £28m Project milestones ZIM: First Nightshift Gold Resource for Mining
Kavango Resources plc (LSE:KAV), the Southern Africa focused metals exploration and gold production company, is pleased to announce confirmation of an open-pit gold deposit at the Nightshift Prospect ("Nightshift") on the Hillside Gold Project ("Hillside"), …
20 Oct Character Group CCT £52m Routine Transaction in Own Shares and Total Voting Rights
20 Oct Faron Pharmaceuticals Oy FARN £66m Updated BEXMAB Phase I/II Data presented at ESMO 2025 shows further improvement, strengthening the clinical profile of bexmarilimab in treatment-naïve HR-MDS patients
Updated BEXMAB Phase I/II Data presented at ESMO 2025 shows further improvement, strengthening the clinical profile of bexmarilimab in treatment-naïve HR-MDS patients with an 85% ORR and a 45% CR rate, bolstered by pharmacodynamic insights
20 Oct OSB Group OSB £1,615m Routine OSB GROUP PLC - Transaction in Own Shares
20 Oct Kenmare Resources (CDI) KMR £200m Holding Holding(s) in Company

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note